BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19880553)

  • 1. Discordant assessment of lupus activity between patients and their physicians: the Singapore experience.
    Leong KP; Chong EY; Kong KO; Chan SP; Thong BY; Lian TY; Chng HH; Koh ET; Teh CL; Lau TC; Law WG; Cheng YK; Badsha H; Chew LC; Yong WH; Howe HS;
    Lupus; 2010 Jan; 19(1):100-6. PubMed ID: 19880553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of discordance between patients and physicians in their assessment of lupus disease activity.
    Yen JC; Abrahamowicz M; Dobkin PL; Clarke AE; Battista RN; Fortin PR
    J Rheumatol; 2003 Sep; 30(9):1967-76. PubMed ID: 12966600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
    Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
    J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore.
    Thumboo J; Fong KY; Ng TP; Leong KH; Feng PH; Thio ST; Boey ML
    J Rheumatol; 1999 Jan; 26(1):97-102. PubMed ID: 9918248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
    Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity.
    Chang ER; Abrahamowicz M; Ferland D; Fortin PR
    J Rheumatol; 2002 Nov; 29(11):2350-8. PubMed ID: 12415591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
    Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA
    J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rheumatology Attitudes Index and its helplessness subscale are valid and reliable measures of learned helplessness in Asian patients with systemic lupus erythematosus.
    Thumboo J; Fong KY; Chan SP; Leong KH; Feng PH; Thio ST; Boey ML
    J Rheumatol; 1999 Jul; 26(7):1512-7. PubMed ID: 10405938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus.
    Brunner HI; Higgins GC; Wiers K; Lapidus SK; Olson JC; Onel K; Punaro M; Ying J; Klein-Gitelman MS; Seid M
    J Rheumatol; 2009 Jul; 36(7):1536-45. PubMed ID: 19487266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores.
    Alarcón GS; McGwin G; Brooks K; Roseman JM; Fessler BJ; Sanchez ML; Bastian HM; Friedman AW; Baethge BA; Reveille JD;
    Arthritis Rheum; 2002 Aug; 47(4):408-13. PubMed ID: 12209488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus.
    Gordon C; Wallace DJ; Shinada S; Kalunian KC; Forbess L; Braunstein GD; Weisman MH
    Rheumatology (Oxford); 2008 Mar; 47(3):334-8. PubMed ID: 18238794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.
    Wollaston SJ; Farewell VT; Isenberg DA; Gordon C; Merrill JT; Petri MA; Kalunian KC;
    J Rheumatol; 2004 Dec; 31(12):2390-4. PubMed ID: 15570639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus.
    Karlson EW; Liang MH; Eaton H; Huang J; Fitzgerald L; Rogers MP; Daltroy LH
    Arthritis Rheum; 2004 Jun; 50(6):1832-41. PubMed ID: 15188360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participatory patient-physician communication and morbidity in patients with systemic lupus erythematosus.
    Ward MM; Sundaramurthy S; Lotstein D; Bush TM; Neuwelt CM; Street RL
    Arthritis Rheum; 2003 Dec; 49(6):810-8. PubMed ID: 14673968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
    Griffiths B; Mosca M; Gordon C
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage.
    Ruperto N; Buratti S; Duarte-Salazar C; Pistorio A; Reiff A; Bernstein B; Maldonado-Velázquez MR; Beristain-Manterola R; Maeno N; Takei S; Falcini F; Lepore L; Spencer CH; Pratsidou-Gertsi P; Martini A; Ravelli A
    Arthritis Rheum; 2004 Jun; 51(3):458-64. PubMed ID: 15188334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.